Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Mirati Therapeutics, Inc. (MRTX)
|
|
| Operating Efficiency |
|
|
|
|
Annual |
|
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| | Source | Source | Source | Source | Source | Source | Source | Source |
| Turnover Ratios |
| Inventory turnover | 0.4 | | | | | | | |
| Asset turnover | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 |
| |
| Returns on Capital |
| ROIC (excluding intangibles) | -81.8% | -71.3% | -81.9% | -87.0% | -96.6% | -209.0% | -170.3% | -139.1% |
| ROIC (including intangibles) | -92.7% | -54.8% | -65.6% | -65.5% | -59.9% | -173.3% | -308.3% | -90.9% |
| ROE | -76.3% | -41.3% | -27.1% | -58.1% | -50.9% | -49.9% | -173.4% | -54.8% |
| ROA | -63.2% | -36.3% | -25.0% | -51.4% | -44.9% | -45.5% | -132.1% | -50.6% |
| |
| Cash Conversion Cycle |
| Days sales outstanding | 25.4 | 0.0 | 0.0 | 0.0 | 0.0 | | | |
| Days payables outstanding | 23,640.4 | | | | | | | |
| Days inventory outstanding | 1,837.2 | | | | | | | |
| Cash conversion cycle | -21,777.9 | | | | | | | |
|